Edison, NJ, United States of America

Suxing Liu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Suxing Liu: Innovator in Pharmaceutical Chemistry

Introduction

Suxing Liu is a notable inventor based in Edison, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds three patents that focus on innovative compounds with therapeutic applications. His work primarily revolves around benzimidazole derivatives, which have significant implications in treating various diseases.

Latest Patents

Liu's latest patents include the development of benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ). These inventions describe compounds that act as inhibitors of the RORγ protein, along with pharmaceutical compositions containing these compounds. The patents detail preparation methods and the therapeutic uses of these compounds for treating RORγ-mediated diseases or disorders.

Career Highlights

Throughout his career, Suxing Liu has worked with prominent companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Liu has collaborated with several professionals in his field, including Rumin Zhang and Feng He. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Suxing Liu's work in pharmaceutical chemistry, particularly with benzimidazole derivatives, showcases his innovative spirit and dedication to advancing medical science. His patents reflect significant contributions to the treatment of RORγ-mediated diseases, marking him as a key figure in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…